Abstract
Background. New drug perspectives raise hopes for the first-line treatment of metastatic renal cell carcinoma (mRCC). ObjectiveCurrent first-line ther......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
